Condition: Parkinson Disease · Sponsor: Insel Gruppe AG, University Hospital Bern
This pilot study aims to evaluate the feasibility and acceptability of nocturnal translational vestibular stimulations (VS) applied by a rocking bed (Somnomat Casa) for two months in patients with Parkinson's Disease.
This description comes directly from the study's public registry record.
Lenard Lachenmayer, MD · 31 66 4 12 59 · lenard.lachenmayer@insel.ch
Always discuss trial participation with your own doctor first.
| Insel Gruppe AG, University Hospital Bern | Bern, Switzerland | Recruiting |
| ETH Zurich, Sensory-Motor Systems Lab, IRIS | Zurich, Switzerland | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06386497